Press "Enter" to skip to content

Aytu Biopharma Files Form 10-K Annual Report with SEC

Aytu Biopharma Files Annual Report Form 10-K with SEC on October 12, 2023 for fiscal year ending June 30, 2023. Aytu Biopharma is exploring use of ultraviolet disinfection with Healight esophogeal explorative device.Full text of Form 10-K available at: https://tinyurl.com/ynmtsm4rCOMPANY OVERVIEWAytu BioPharma, Inc. (“Aytu,” the “Company”, “we”) is a pharmaceutical company focused on commercializing novel…

This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.